{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:27:18Z","timestamp":1792045638953,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["DD1144 A629-ISA"],"award-info":[{"award-number":["DD1144 A629-ISA"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006751","name":"U.S. Army","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.omtn.2022.05.025","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T12:21:29Z","timestamp":1652185289000},"page":"847-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4656-5379","authenticated-orcid":false,"given":"Eric M.","family":"Mucker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Thiele-Suess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Baumhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4475-0415","authenticated-orcid":false,"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2022.05.025_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/erv.11.46","article-title":"The strategic use of novel smallpox vaccines in the post-eradication world","volume":"10","author":"Golden","year":"2011","journal-title":"Expert Rev. Vaccin."},{"key":"10.1016\/j.omtn.2022.05.025_bib2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1542\/peds.26.2.176","article-title":"Studies smallpox and complications of smallpox vaccination","volume":"26","author":"Kempe","year":"1960","journal-title":"Pediatrics"},{"key":"10.1016\/j.omtn.2022.05.025_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(73)92215-0","article-title":"Experience of anti-vaccinia immunoglobulin in the United Kingdom","volume":"301","author":"Sharp","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2022.05.025_bib4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3390\/v2102381","article-title":"Therapeutic vaccines and antibodies for treatment of orthopoxvirus infections","volume":"2","author":"Xiao","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2022.05.025_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1743-422X-8-441","article-title":"Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease","volume":"8","author":"Golden","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.omtn.2022.05.025_bib6","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2022.05.025_bib7","doi-asserted-by":"crossref","first-page":"e48706","DOI":"10.1371\/journal.pone.0048706","article-title":"Protection of rabbits and immunodeficient mice against lethal poxvirus infections by human monoclonal antibodies","volume":"7","author":"Crickard","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.05.025_bib8","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1128\/JVI.00121-11","article-title":"Passive immunotherapies protect WRvFire and IHD-J-Luc vaccinia virus-infected mice from lethality by reducing viral loads in the upper respiratory tract and internal organs","volume":"85","author":"Zaitseva","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2022.05.025_bib9","first-page":"295","article-title":"Humoral and cellular aspects of the response to infection: Protection against poxviruses","volume":"62","author":"Boulter","year":"1969","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.omtn.2022.05.025_bib10","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/oxfordjournals.aje.a121360","article-title":"The nature of the immune state produced by inactivated vaccinia virus in rabbits","volume":"94","author":"Boulter","year":"1971","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.omtn.2022.05.025_bib11","first-page":"86","article-title":"Differences between extracellular and intracellular forms of poxvirus and their implications","volume":"16","author":"Boulter","year":"1973","journal-title":"Prog. Med. Virol."},{"key":"10.1016\/j.omtn.2022.05.025_bib12","doi-asserted-by":"crossref","first-page":"e42353","DOI":"10.1371\/journal.pone.0042353","article-title":"Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates","volume":"7","author":"Golden","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2022.05.025_bib13","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1038\/srep12616","article-title":"Protection against dengue disease by synthetic nucleic acid antibody prophylaxis\/immunotherapy","volume":"5","author":"Flingai","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.05.025_bib14","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/infdis\/jiw111","article-title":"Rapid and long-term immunity elicited by DNA-encoded antibody prophylaxis and DNA vaccination against chikungunya virus","volume":"214","author":"Muthumani","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtn.2022.05.025_bib15","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.4161\/hv.26498","article-title":"Optimized and enhanced DNA plasmid vector based in\u00a0vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab","volume":"9","author":"Muthumani","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.omtn.2022.05.025_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4939-2432-5_8","article-title":"Vector-mediated antibody gene transfer for infectious diseases","volume":"848","author":"Schnepp","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtn.2022.05.025_bib17","doi-asserted-by":"crossref","first-page":"8764","DOI":"10.1038\/s41598-020-65059-0","article-title":"Lipid nanoparticle formulation increases efficiency of DNA-vectored vaccines\/immunoprophylaxis in animals including transchromosomic bovines","volume":"10","author":"Mucker","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2022.05.025_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2022.05.025_bib19","doi-asserted-by":"crossref","first-page":"e0006581","DOI":"10.1371\/journal.pntd.0006581","article-title":"Intranasal monkeypox marmoset model: prophylactic antibody treatment provides benefit against severe monkeypox virus disease","volume":"12","author":"Mucker","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.omtn.2022.05.025_bib20","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1073\/pnas.0510598103","article-title":"Chimpanzee\/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtn.2022.05.025_bib21","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1128\/JVI.00906-07","article-title":"Characterization of chimpanzee\/human monoclonal antibodies to vaccinia virus A33 glycoprotein and its variola virus homolog in\u00a0vitro and in a vaccinia virus mouse protection model","volume":"81","author":"Chen","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2022.05.025_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.virol.2020.02.004","article-title":"Particle-specific neutralizing activity of a monoclonal antibody targeting the poxvirus A33 protein reveals differences between cell associated and extracellular enveloped virions","volume":"544","author":"Mucker","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.omtn.2022.05.025_bib23","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/clpt.2008.170","article-title":"Monoclonal antibody pharmacokinetics and pharmacodynamics","volume":"84","author":"Wang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2022.05.025_bib24","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1566523214666140522122633","article-title":"A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates","volume":"14","author":"Kwilas","year":"2014","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omtn.2022.05.025_bib25","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","volume":"390","author":"Alberer","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2022.05.025_bib26","doi-asserted-by":"crossref","first-page":"eaaw6647","DOI":"10.1126\/sciimmunol.aaw6647","article-title":"A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection","volume":"4","author":"Kose","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.omtn.2022.05.025_bib27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2022.05.025_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.omtn.2022.05.025_bib29","doi-asserted-by":"crossref","first-page":"14630","DOI":"10.1038\/ncomms14630","article-title":"Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge","volume":"8","author":"Pardi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2022.05.025_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","article-title":"Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA","volume":"23","author":"Kariko","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2022.05.025_bib31","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.omtn.2022.05.025_bib32","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4161\/mabs.25234","article-title":"Immunogenicity of mAbs in non-human primates during nonclinical safety assessment","volume":"5","author":"van Meer","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.omtn.2022.05.025_bib33","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/mt.2015.103","article-title":"Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals","volume":"23","author":"Thess","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2022.05.025_bib34","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.15252\/emmm.201707678","article-title":"mRNA mediates passive vaccination against infectious agents, toxins, and tumors","volume":"9","author":"Thran","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omtn.2022.05.025_bib35","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.omtn.2022.05.025_bib36","first-page":"372","article-title":"Immune modulatory nanoparticle therapeutics for intracerebral glioma","volume":"19","author":"Yaghi","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.omtn.2022.05.025_bib37","doi-asserted-by":"crossref","first-page":"e0131742","DOI":"10.1371\/journal.pone.0131742","article-title":"Susceptibility of marmosets (Callithrix jacchus) to monkeypox virus: a low dose prospective model for monkeypox and smallpox disease","volume":"10","author":"Mucker","year":"2015","journal-title":"PLoS One"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312200138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S216225312200138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T01:31:59Z","timestamp":1761874319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S216225312200138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"alternative-id":["S216225312200138X"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2022.05.025","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2022.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}